Table 1.
Variable | Characteristic | No Patients (%) |
---|---|---|
Sex | Female | 19 (35.2) |
Male | 35 (64.8) | |
Immunophenotyping | T-lineage | 40 (74.1) |
B-lineage | 14 (25.9) | |
Stage category | stage Ⅲ | 30 (55.6) |
stage Ⅳ | 24 (44.4) | |
Chemotherapy | NHL-BFM-95 protocol | 23 (42.6) |
modified NHL-BFM-95 protocol | 31 (57.4) |
NHL-BFM-95 protocol: Non-Hodgkin Lymphoma– Berlin-Frankfurt-Munster-95 protocol